Provided by Tiger Fintech (Singapore) Pte. Ltd.

VolitionRX

0.5030
+0.01493.05%
Post-market: 0.4947-0.0083-1.65%17:46 EDT
Volume:242.92K
Turnover:123.76K
Market Cap:51.82M
PE:-1.85
High:0.5200
Open:0.4800
Low:0.4773
Close:0.4881
Loading ...

Company Profile

Company Name:
VolitionRX
Exchange:
AMEX
Establishment Date:
- -
Employees:
85
Office Location:
1489 West Warm Springs Road,Suite 110,Henderson,Nevada,United States
Zip Code:
89014
Fax:
- -
Introduction:
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.

Directors

Name
Position
Cameron Reynolds
President,Chief Executive Officer and Director
Martin Faulkes
Executive Chairman and Director
Alan Colman
Director
Edward Futcher
Director
Guy Innes
Director
Habib Skaff
Director

Shareholders

Name
Position
Cameron Reynolds
President,Chief Executive Officer and Director
David Vanston
Chief Financial Officer and Treasurer
Jacob Micallef
Chief Scientific Officer
Jason Terrell
Chief Medical Officer and Head of U.S. Operations
Martin Faulkes
Executive Chairman and Director
Rodney Rootsaert
Corporate Secretary